Colorectal cancer metastatic

• A Randomized, Double-Blind, Phase 3 Study of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treat … Pending
  2025-523735-19-00 5 "Metastatic Microsatellite Stable Colorectal Cancer"
• The SEAMARK Study: Phase 2 Study of First-line Encorafenib and Cetuximab Plus Pembrolizumab in Participants With BRAF V600E-mutant,MSIH/dMMR … Recruiting
  2024-512119-34-00 4 2022-06-20 "MSI-H/dMMR metastatic colorectal cancer"
• Phase III study in first-line treatment of patients with metastatic colorectal cancer who are not candidate for intensive therapy. (SOLSTICE … Recruiting
  2024-516180-85-00 5 2019-04-15 "Metastatic colorectal cancer"
• A clinical study to test if an investigational treatment called BNT314 when used in combination with another investigational treatment pumit … Recruiting
  2025-521768-36-00 9 2026-01-27 "Metastatic colorectal cancer"
• Regorafenib as second-line treatment of patients with RAS-mutant advanced colorectal cancer: a multicentre, phase 2 study - STREAM-2 Recruiting
  2024-519669-23-00 4 2025-09-29 "Patients with metastatic colorectal cancer (mCRC) RAS-mutant"
• metastatic colorectal cancer Recruiting
  2023-504831-42-00 5 2025-06-27 "patient with colorectal cancer with hepatic metastasis"
• Sequential immunochemotherapy treatment with Pembrolizumab plus Dendritic Cell (DC) Vaccine followed by Trifluridine/Tipiracil plus Bevacizu … Recruiting
  2024-514053-30-00 4 2025-01-07 "Metastatic colorectal cancer"
• Randomized phase 2 study of Valproic acid combinEd with rechallenge anti-EGFR based regimen regimens in pretreated patients with RAS/BRAF wi … Recruiting
  2024-514420-16-00 4 2024-12-18 "RAS/BRAF wild-type metastatic colorectal cancer"
• The detection of tumor-associated fibrosis in colorectal peritoneal metastases by FAPI-PET (TROMPET) Recruiting
  2024-512301-16-01 3 2024-12-12 "Metastatic colorectal cancer"
• Molecular imaging with FAPI for diagnosing the CSM4 colorectal cancer subtype Recruiting
  2023-509183-17-00 3 2024-08-01 "Colorectal cancer, liver metastases"
• CARE : Impact of Regorafenib in combination with multimodal metronomic chemotherapy (cyclophosphamide, capecitabine, and low-dose aspirin) o … Recruiting
  2023-509761-21-00 5 2024-07-08 "Metastatic colorectal cancer"
• Randomized phase 3 study of intermittent or continuous Panitumumab plus FOLFIRI for first-line treatment of patients with unresectable left … Recruiting
  2023-509551-14-00 5 2024-06-12 "Unresectable left sided RAS/B-RAF wild-type metastatic color"
• Phase I/II study with galunisertib combined with capecitabine in patients with advanced chemotherapy resistant colorectal cancer with perito … Recruiting
  2024-518980-37-00 9 2023-07-12 "colorectal cancer"
• EVIDENT Recruiting
  2023-510092-62-00 4 2022-09-27 "Colorectal cancer"
• CETUXIMAB, IRINOTECAN AND FLUOROURACILE IN FIRST-LINE TREATMENT OF IMMUNOLOGICALLY-SELECTED ADVANCED COLORECTAL CANCER PATIENTS - the CIFRA … Recruiting
  2024-518987-11-00 4 2019-06-12 "ADCC"
• Phase 1/2 dose escalation and cohort expansion study evaluating MCLA-158 (petosemtamab) as single agent or in combination in advanced solid … Recruiting
  2024-513627-16-01 7 2018-03-28
• Vaccination with autologous dendritic cells loaded with autologous tumour homogenate after curative resection for stage IV colorectal cancer … Recruiting
  2024-516221-31-00 4 2016-04-19 "Stage IV colorectal cancer"
• Study to Assess Adverse Events and Change in Disease Activity in Previously Treated Adult Participants Receiving Intravenous (IV) ABBV-400 W … Recruitment ended
  2023-505110-14-00 4 2024-12-02 "Colorectal Cancer"
• A phase 1/2 multiple-indication biomarker, safety, and efficacy study in advanced or metastatic Gastrointestinal cancers exploring treatment … Recruitment ended
  2024-515936-62-00 9 2024-10-10 "Patients with advanced or metastatic gastrointestinal (GI) t"
• Randomized and multicentre Phase II study of FOLFOX6m + monoclonal Ab (anti-EGFR or bevacizumab) alone or in combination with hepatic chemoe … Recruitment ended
  2024-517782-16-00 4 2024-10-10 "Colorectal cancer and metastatic disease limited to the live"
• Study Title: Single cell characterization of persistent cells upon treatment with durvalumab (MEDI4736) with or without Tremelimumab in MSS … Recruitment ended
  2023-509619-10-00 4 2024-08-29 "MSS and MSI colorectal and endometrial tumors"
• Phase I study of AZD9592 in solid tumors Recruitment ended
  2022-501570-18-00 1 2023-07-18 "Recurrent or metastatic Head and NeckSquamous Cell Carcinoma"
• A Phase 1/2a study of PF-07220060 in Participants with Advanced Solid Tumors Recruitment ended
  2024-512120-11-00 7 2022-08-31 "Part 2A, 2B, 2C & 2E HR-positive /HER2-negative breast cance"
• A Randomized Phase 3 Study of MRTX849 in Combination with Cetuximab Versus Chemotherapy in Patients with Advanced Colorectal Cancer with KRA … Recruitment ended
  2023-506241-30-00 5 2021-11-30 "Advanced Colorectal Cancer with KRAS G12C Mutation"

Showing 1–24 of 36 trials